Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Une chercheuse qui manipule

What is translational research?

Improving human health as an objective

Last update: 19/05/2025 Reading time: 1min

Translational research aims to transform discoveries, observations and ideas developed in the laboratory into practical applications with the objective of improving human health. This process is often described as a "bench-to-bench" approach from laboratories to patients’ beds, reflecting the fact that basic knowledge from basic research is converted into new therapies, treatments, diagnostics or clinical procedures.

From Discovery to Clinical Application

From Discovery to Clinical Application

Translational research is at the interface between basic and clinical research.
So-called fundamental scientists discover new biological, genetic or physiological processes, often without any direct and immediate application. Translational scientists build on these discoveries and explore how they can be used to diagnose, prevent or treat diseases. Clinical scientists assess the safety and efficacy of clinical trials in healthy or ill volunteers.
 

Phases of Translational Research

Phases of Translational Research

Translational research is generally divided into two main phases:

  • the first translational phase involves the translation of knowledge from basic research into a potential concept or product for clinical use. This often includes the development of drugs, medical devices, diagnostics or even therapies;
  • the second translational phase is to translate these concepts or products into actual clinical applications, including clinical trials and the evaluation of their efficacy and safety in humans.
     
The Challenges of Translational Research

The Challenges of Translational Research

Translational research faces many challenges. One of the most significant is the one referred to as the "valley of death" which describes the difficulty of moving from basic research to clinical applications. Financial, regulatory and logistical obstacles all play a role in this challenge, which requires strong responses.
 

Interdisciplinary collaboration

Interdisciplinary collaboration

A critical aspect of translational research is collaboration across diverse fields. Biologists, physicians, pharmacologists, bioinformaticians, engineers and other professionals must work together to effectively translate scientific discoveries into clinical treatments.

Funding and Support

Funding and Support

Funding for translational research comes from a variety of sources, including governments, private institutions and the generosity of the public.

Support research at Paris Brain Institute

You can support research by making a donation to Paris Brain Institute.

Click here
Impact on Public Health

Impact on Public Health

The impact of translational research on public health is profound. It has led to the development of many revolutionary treatments, significantly improving the quality of life of patients and, in some cases, saving lives.

The Future of Translational Research

The Future of Translational Research

With continuing advances in science and technology, including genomics, artificial intelligence and biotechnology, the potential for translational research continues to grow. The future promises more personalized approaches to medicine, faster and more accurate diagnosis, and more effective treatments for an ever-widening range of diseases.

Translational Research at Paris Brain Institute

Translational Research at Paris Brain Institute

Paris Brain Institute was conceived with the objective of eliminating as much as possible the theoretical, material and financial barriers between basic research, applied research, clinical research, translational research, etc. That is why Paris Brain Institute brings together researchers, clinicians, patients, startups and much more to maximize interactions, create simulations and accelerate clinical applications.
Thus, hypotheses proposed in basic research can be tested or invalidated clinically, and clinical observations can serve as the genesis for basic research projects, mobilizing multiple research teams and enabling the development of solutions.

News that might interest you

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news